ArticleCancer discovery2017

Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer.

Dennis O Adeegbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.